Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants

Francesco Savino1, Lisa Cordisco, Valentina Tarasco

  • 1Department of Pediatrics, Regina Margherita Children Hospital, Torino, Italy. francesco.savino@unito.it

BMC Microbiology
|July 2, 2011
PubMed

Insights

Two Lactobacillus strains inhibited gas-producing coliforms linked to infantile colic. This research may lead to new probiotic treatments for colic by targeting gut bacteria.

Area of Science:

  • Microbiology
  • Infant Health
  • Gastroenterology

Background:

  • Infantile colic is a common infant issue with unknown causes, possibly linked to intestinal gas.
  • The role of gut microbiota gas production in colic is not well understood.
  • Lactobacilli supplementation shows promise, but mechanisms require clarification.

Purpose of the Study:

  • To investigate the interaction between Lactobacillus strains and gas-forming coliforms in colicky infants.
  • To assess the potential of Lactobacillus species in managing colic-related gut issues.

Main Methods:

  • Coliforms were isolated from stools of colicky and control infants.
  • Gas-forming capability of coliforms was assessed.
  • 27 Lactobacillus strains were tested for antagonistic effects against coliforms using halo-forming and co-culture methods.

Main Results:

  • Colicky infants had significantly higher total coliform counts than controls.
  • Identified coliforms included Escherichia coli and Klebsiella pneumoniae.
  • Lactobacillus delbrueckii subsp. delbrueckii DSM 20074 and L. plantarum MB 456 inhibited all tested coliforms.

Conclusions:

  • Two Lactobacillus strains demonstrated antimicrobial activity against gas-forming coliforms from colicky infants.
  • These findings suggest potential for specific Lactobacillus strains in managing infantile colic by targeting coliform colonization.
Abstract

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Microbes in the Production of Fermented Foods01:27

Microbes in the Production of Fermented Foods

Lactic acid bacteria (LAB) and molds are instrumental in fermenting plant-based foods to enhance preservation and ensure year-round availability. These microbial processes convert plant carbohydrates into organic acids and other metabolites that inhibit spoilage organisms and contribute to the sensory qualities of the final product.In sauerkraut production, cabbage goes through a microbial succession that starts with cocci such as Leuconostoc mesenteroides. These microbes begin fermentation by...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...